EQT's Strategic Acquisition of TachoSil® from Corza Medical
EQT is set to acquire the TachoSil® biosurgery business from Corza Medical, a move poised to bolster its position in surgical technologies. TachoSil®, renowned for its dual-action hemostatic and sealing properties, will now benefit from EQT's strategic backing. This transaction …
Read more →
